L. Becker Hewes Blueprint Medicines Corp (BPMC) insider trading activity

BPMC Quotes by TradingView

L. Becker Hewes is Chief Medical Officer of Blueprint Medicines Corp. Currently has a direct ownership of 0 shares of BPMC, which is worth approximately $0. The most recent transaction as insider was on Jul 17, 2025, when has been sold 50,165 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

L. Becker Hewes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 17 2025
SELL
Sale (or disposition) back to the issuer
-
50,165 Reduced 96.9%
1,607 Common Stock
Jul 17 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
1,607 Reduced 100.0%
0 Common Stock
Jul 17 2025
BUY
Grant, award, or other acquisition
-
21,353 Added 29.2%
51,772 Common Stock
Mar 06 2025
SELL
Open market or private sale
$458,846 $87.7 p/Share
5,232 Reduced 14.68%
30,419 Common Stock
Mar 05 2025
SELL
Open market or private sale
$431,834 $88.8 p/Share
4,863 Reduced 12.0%
35,651 Common Stock
Mar 01 2025
BUY
Grant, award, or other acquisition
-
11,000 Added 21.35%
40,514 Common Stock
Jun 04 2024
SELL
Open market or private sale
$254,301 $104.91 p/Share
2,424 Reduced 7.59%
29,514 Common Stock
Jun 03 2024
SELL
Open market or private sale
$523,848 $106.43 p/Share
4,922 Reduced 13.35%
31,938 Common Stock
May 31 2024
SELL
Open market or private sale
$3,623,975 $106.25 p/Share
34,108 Reduced 48.06%
36,860 Common Stock
May 31 2024
BUY
Exercise of conversion of derivative security
$1,404,690 $56.9 p/Share
24,687 Added 25.81%
70,968 Common Stock
Mar 07 2024
SELL
Open market or private sale
$280,866 $90.69 p/Share
3,097 Reduced 6.27%
46,281 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
12,500 Added 20.2%
49,378 Common Stock
Jun 05 2023
SELL
Open market or private sale
$73,078 $52.05 p/Share
1,404 Reduced 3.67%
36,878 Common Stock
Mar 06 2023
SELL
Open market or private sale
$68,508 $45.25 p/Share
1,514 Reduced 3.8%
38,282 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
12,500 Added 23.9%
39,796 Common Stock
Jun 07 2022
SELL
Open market or private sale
$189,300 $60.0 p/Share
3,155 Reduced 10.36%
27,296 Common Stock
Jun 06 2022
SELL
Open market or private sale
$72,907 $59.76 p/Share
1,220 Reduced 3.85%
30,451 Common Stock
Mar 16 2022
SELL
Open market or private sale
$133,140 $60.0 p/Share
2,219 Reduced 6.55%
31,671 Common Stock
Mar 07 2022
SELL
Open market or private sale
$58,831 $56.19 p/Share
1,047 Reduced 3.0%
33,890 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
8,750 Added 20.03%
34,937 Common Stock
Dec 15 2021
SELL
Open market or private sale
$72,900 $100.0 p/Share
729 Reduced 2.71%
26,187 Common Stock
Dec 15 2021
BUY
Exercise of conversion of derivative security
$48,289 $66.24 p/Share
729 Added 2.64%
26,916 Common Stock
Nov 15 2021
SELL
Open market or private sale
$84,192 $115.49 p/Share
729 Reduced 2.71%
26,187 Common Stock
Nov 15 2021
BUY
Exercise of conversion of derivative security
$48,289 $66.24 p/Share
729 Added 2.64%
26,916 Common Stock
Oct 15 2021
SELL
Open market or private sale
$74,839 $102.66 p/Share
729 Reduced 2.71%
26,187 Common Stock
LBH

L. Becker Hewes

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BPMC